Antimicrobial Agents — MCQs
On this page
What is the role of ethambutol in the Revised National Tuberculosis Control Programme (RNTCP) regimen?
A person on anti-tubercular drugs complained of deafness and tinnitus in one ear. Which drug is most likely implicated?
Efavirenz limits HIV infection by:
Which of the following is NOT a potential adverse effect of fluoroquinolones?
Tetracycline in children causes what?
A female patient treated with antibiotics for chlamydia-induced UTI presents with itching/pruritus, vaginal discharge, and burning micturition. Which drug should be given?
Which of the following is a fifth-generation cephalosporin?
Which of the following drugs acts by inhibiting cell wall synthesis?
What is the mechanism of action of Oseltamivir and Zanamivir?
Which of the following antimicrobial agents inhibits protein synthesis by blocking translocation?
Antimicrobial Agents Indian Medical PG Practice Questions and MCQs
Question 271: What is the role of ethambutol in the Revised National Tuberculosis Control Programme (RNTCP) regimen?
- A. Bactericidal and detrimental to semidormant bacilli
- B. Bactericidal and detrimental to dormant bacilli
- C. Bacteriostatic and detrimental to fast multiplying bacilli (Correct Answer)
- D. Bacteriostatic and detrimental to slow multiplying bacilli
Explanation: ### Explanation **1. Why the Correct Answer is Right:** Ethambutol is a **bacteriostatic** antitubercular drug. Its primary mechanism of action involves the inhibition of the enzyme **arabinosyl transferase**, which is essential for the synthesis of arabinogalactan (a critical component of the mycobacterial cell wall). Since cell wall synthesis occurs most actively during cell division, ethambutol is most effective against **fast-multiplying bacilli** (extracellular bacteria). By inhibiting wall synthesis, it prevents the multiplication of the bacteria rather than killing them directly. **2. Why the Other Options are Wrong:** * **Options A & B (Bactericidal):** Ethambutol is the only primary antitubercular drug that is bacteriostatic at standard therapeutic doses. Drugs like Isoniazid, Rifampicin, and Pyrazinamide are bactericidal. * **Options B & D (Dormant/Slow multiplying):** Ethambutol has no significant activity against dormant (latent) or slow-multiplying (intracellular) bacilli. **Pyrazinamide** is the drug of choice for acidic environments (intracellular/slow-multiplying), while **Rifampicin** is highly effective against spurters (semidormant bacilli). **3. NEET-PG High-Yield Clinical Pearls:** * **Visual Side Effects:** The most characteristic side effect is **Retrobulbar Neuritis**, leading to decreased visual acuity, central scotoma, and **red-green color blindness**. It is generally dose-dependent and reversible. * **Contraindication:** It should be avoided in children below 6 years of age because they cannot reliably report changes in visual acuity or color perception. * **Uric Acid:** Like Pyrazinamide, Ethambutol can decrease the excretion of uric acid, potentially leading to **hyperuricemia**. * **Role in RNTCP:** Its primary role in the Intensive Phase (2HRZE) is to prevent the emergence of resistance to more potent drugs like Isoniazid and Rifampicin.
Question 272: A person on anti-tubercular drugs complained of deafness and tinnitus in one ear. Which drug is most likely implicated?
- A. Streptomycin (Correct Answer)
- B. Isoniazid
- C. Ethambutol
- D. Rifampicin
Explanation: **Explanation:** The correct answer is **Streptomycin**. **1. Why Streptomycin is correct:** Streptomycin is an **Aminoglycoside** antibiotic used as a first-line injectable drug in the treatment of Tuberculosis. The hallmark toxicity of aminoglycosides is **ototoxicity**, which occurs due to the destruction of sensory hair cells in the inner ear. Streptomycin specifically targets the **vestibulocochlear nerve (Cranial Nerve VIII)**. While it is more vestibulotoxic (causing vertigo and ataxia), it also causes permanent cochlear damage, leading to **tinnitus and sensorineural hearing loss (deafness)**. **2. Why the other options are incorrect:** * **Isoniazid (INH):** The most characteristic side effect is **peripheral neuropathy** (due to Vitamin B6 deficiency) and hepatotoxicity. It does not affect hearing. * **Ethambutol:** The classic adverse effect is **retrobulbar neuritis**, which manifests as decreased visual acuity and **red-green color blindness**. It is not ototoxic. * **Rifampicin:** Known for causing **orange-colored discoloration** of body fluids (urine, sweat, tears) and hepatotoxicity. It does not cause deafness. **Clinical Pearls for NEET-PG:** * **Ototoxicity:** Streptomycin is more vestibulotoxic, whereas Amikacin and Kanamycin are more cochleotoxic. * **Pregnancy:** Streptomycin is **contraindicated in pregnancy** because it can cross the placenta and cause congenital deafness in the fetus. * **Renal Monitoring:** Since aminoglycosides are excreted unchanged by the kidneys, dose adjustment is required in renal failure to prevent both ototoxicity and nephrotoxicity. * **Mnemonic for Ethambutol:** **E**thambutol for **E**ye (Optic neuritis).
Question 273: Efavirenz limits HIV infection by:
- A. Binding to the active site of HIV reverse transcriptase
- B. Impairing the binding of HIV virion to CD4 receptors on T-cells
- C. Inhibiting the HIV protease
- D. Serving as an allosteric inhibitor of HIV reverse transcriptase (Correct Answer)
Explanation: **Explanation:** **Efavirenz** is a **Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)**. Unlike Nucleoside Reverse Transcriptase Inhibitors (NRTIs) like Zidovudine, which act as competitive substrate analogues, NNRTIs do not bind to the active site. Instead, they bind to a specific **hydrophobic pocket** (NNRTI-binding pocket) adjacent to the active site of the HIV-1 Reverse Transcriptase enzyme. This binding induces a conformational change that reduces the enzyme's catalytic activity, acting as a non-competitive, **allosteric inhibitor**. **Analysis of Options:** * **Option A:** Binding to the active site is the mechanism of **NRTIs** (e.g., Tenofovir, Abacavir). They compete with natural deoxynucleotides. * **Option B:** Impairing binding to CD4 receptors describes **Entry Inhibitors** like **Ibalizumab** (CD4-directed post-attachment inhibitor) or **Maraviroc** (CCR5 antagonist). * **Option C:** Inhibiting HIV protease is the mechanism of **Protease Inhibitors (PIs)** like Atazanavir and Darunavir, which prevent the cleavage of gag-pol polyproteins into functional units. **High-Yield Clinical Pearls for NEET-PG:** * **Spectrum:** NNRTIs are active only against **HIV-1**, not HIV-2. * **CNS Side Effects:** Efavirenz is notorious for causing neuropsychiatric symptoms (vivid dreams, dizziness, "hangover" feeling, and depression). * **Teratogenicity:** Historically associated with neural tube defects; however, current guidelines suggest it can be continued in pregnancy if viral suppression is achieved. * **Metabolism:** It is a potent inducer of CYP3A4 enzymes.
Question 274: Which of the following is NOT a potential adverse effect of fluoroquinolones?
- A. Abdominal discomfort
- B. Dysglycemia
- C. QT prolongation
- D. Blindness (Correct Answer)
Explanation: **Explanation:** Fluoroquinolones (e.g., Ciprofloxacin, Levofloxacin, Moxifloxacin) are broad-spectrum bactericidal antibiotics that inhibit DNA gyrase and Topoisomerase IV. While they have a wide range of side effects, **blindness** is not a recognized adverse effect of this drug class. * **Why Option D is correct:** Fluoroquinolones are associated with various ocular side effects like blurred vision or, rarely, retinal detachment, but they do **not** cause blindness. In contrast, drugs like Ethambutol (optic neuritis) or Quinine are classic causes of toxic amblyopia/blindness. * **Why other options are incorrect:** * **A. Abdominal discomfort:** GI upset (nausea, vomiting, diarrhea) is the most common side effect of fluoroquinolones. * **B. Dysglycemia:** Fluoroquinolones (especially Gatifloxacin, which was withdrawn for this reason) can cause both hypoglycemia and hyperglycemia by affecting pancreatic K+ channels. * **C. QT prolongation:** Moxifloxacin and Sparfloxacin are notorious for prolonging the QT interval, increasing the risk of Torsades de Pointes. **High-Yield Clinical Pearls for NEET-PG:** * **Musculoskeletal:** They cause **tendon rupture** (Achilles tendon) and arthropathy; thus, they are generally avoided in children and pregnancy. * **CNS:** They can lower the seizure threshold (GABA antagonism). * **Contraindication:** Avoid in **Myasthenia Gravis** as they can exacerbate muscle weakness. * **Phototoxicity:** Patients should be advised to avoid excessive sunlight.
Question 275: Tetracycline in children causes what?
- A. Calcification
- B. Missing teeth
- C. Discolored teeth (Correct Answer)
- D. Peg teeth
Explanation: **Explanation:** The correct answer is **Discolored teeth (Option C)**. **Mechanism of Action:** Tetracyclines are broad-spectrum bacteriostatic antibiotics. They have a high affinity for calcium ions and form a stable **tetracycline-calcium orthophosphate complex**. When administered during the period of tooth development (calcification), this complex is permanently deposited in the dentin and enamel. Under exposure to light, this complex undergoes oxidation, leading to a characteristic **yellowish-brown or gray-brown permanent discoloration** and potential enamel hypoplasia. **Analysis of Incorrect Options:** * **A. Calcification:** Tetracyclines do not cause calcification; rather, they interfere with the process and deposit into tissues that are *already* undergoing calcification (teeth and bones). * **B. Missing teeth (Anodontia):** Tetracyclines do not affect the number of teeth or the formation of tooth buds; they only affect the structure and color of the developing tooth. * **D. Peg teeth:** This refers to a morphological abnormality (like Hutchinson’s teeth in Congenital Syphilis). Tetracyclines affect the color and integrity of the enamel, not the fundamental shape of the tooth. **High-Yield NEET-PG Pearls:** * **Contraindications:** Tetracyclines are strictly contraindicated in **pregnant women** (after the 4th month) and **children below 8 years of age**. * **Bone Growth:** They can also deposit in growing bones, causing a temporary suppression of fibular growth. * **Fanconi Syndrome:** Use of **outdated/expired tetracyclines** leads to Fanconi-like syndrome (renal tubular acidosis) due to degradation products like epianhydrotetracycline. * **Doxycycline:** It is the safest tetracycline in renal failure (excreted via bile) and has a lower affinity for calcium compared to older tetracyclines, though the clinical precaution remains the same.
Question 276: A female patient treated with antibiotics for chlamydia-induced UTI presents with itching/pruritus, vaginal discharge, and burning micturition. Which drug should be given?
- A. Ceftriaxone
- B. Azithromycin (Correct Answer)
- C. Moxifloxacin
- D. Amphotericin B
Explanation: ### **Explanation** **Correct Option: B. Azithromycin** The clinical scenario describes a patient with a **Chlamydial urinary tract infection (UTI)/Urethritis**. *Chlamydia trachomatis* is an obligate intracellular pathogen. **Azithromycin**, a macrolide, is the drug of choice because it achieves high intracellular concentrations and has a long half-life, allowing for a **single-dose (1g)** curative regimen. This ensures high patient compliance compared to multi-day courses. **Analysis of Incorrect Options:** * **A. Ceftriaxone:** This is a third-generation cephalosporin used primarily for *Neisseria gonorrhoeae*. While Chlamydia and Gonorrhea often co-infect, Ceftriaxone is ineffective against Chlamydia because the organism lacks a typical peptidoglycan cell wall (the target of beta-lactams). * **C. Moxifloxacin:** While some fluoroquinolones (like Ofloxacin or Levofloxacin) can treat Chlamydia, they are second-line agents. Moxifloxacin is generally reserved for respiratory infections or resistant Pelvic Inflammatory Disease (PID) and is not the primary choice for uncomplicated Chlamydial UTI. * **D. Amphotericin B:** This is a potent antifungal used for systemic fungal infections (e.g., Mucormycosis). It has no activity against bacterial pathogens like Chlamydia. **NEET-PG High-Yield Pearls:** * **DOC for Chlamydia:** Azithromycin (1g stat) or Doxycycline (100mg BID for 7 days). * **Pregnancy:** Azithromycin is the preferred agent for Chlamydia in pregnant women (Doxycycline is contraindicated due to fetal bone/teeth effects). * **Syndromic Management (Green Kit):** Used for vaginal discharge; contains Fluconazole (for Candidiasis) and Azithromycin (for Chlamydia). * **Reiter’s Syndrome:** A classic triad of "Can't see, can't pee, can't climb a tree" (Uveitis, Urethritis, Arthritis) often triggered by a Chlamydia infection.
Question 277: Which of the following is a fifth-generation cephalosporin?
- A. Cefepime
- B. Ceftaroline (Correct Answer)
- C. Cefpirome
- D. Cefprozil
Explanation: **Explanation:** **Ceftaroline** is the correct answer as it is a member of the **fifth-generation cephalosporins**. The defining clinical characteristic of this generation is its unique ability to bind to **PBP-2a**, an altered penicillin-binding protein that confers resistance in Staphylococci. This makes fifth-generation agents the only cephalosporins effective against **Methicillin-resistant *Staphylococcus aureus* (MRSA)**. **Analysis of Incorrect Options:** * **Cefepime (Option A):** This is a **fourth-generation** cephalosporin. It is a "zwitterion" that can rapidly penetrate the outer membrane of Gram-negative bacteria. It is highly effective against *Pseudomonas aeruginosa* but lacks activity against MRSA. * **Cefpirome (Option C):** Also a **fourth-generation** cephalosporin, similar in spectrum to Cefepime, primarily used for life-threatening nosocomial infections. * **Cefprozil (Option D):** This is a **second-generation** oral cephalosporin used mainly for respiratory tract infections and skin/soft tissue infections. **High-Yield Clinical Pearls for NEET-PG:** * **Fifth-Generation Agents:** Include **Ceftaroline** and **Ceftobiprole**. * **MRSA Coverage:** Remember the mnemonic: "Ceftaroline covers the 'Staph' that others can't." * **VRSA & VISA:** Ceftaroline also shows activity against Vancomycin-resistant and Vancomycin-intermediate *S. aureus*. * **LAME Mnemonic:** Cephalosporins generally do **NOT** cover **L**isteria, **A**typicals (Mycoplasma/Chlamydia), **M**RSA (except 5th gen), and **E**nterococci (except Ceftaroline/Ceftobiprole which have some Enterococcal activity). * **Excretion:** Most cephalosporins are renally excreted; **Ceftriaxone** is a notable exception (biliary excretion), requiring no dose adjustment in renal failure.
Question 278: Which of the following drugs acts by inhibiting cell wall synthesis?
- A. Erythromycin
- B. Cephalosporins (Correct Answer)
- C. Chloramphenicol
- D. Sulfonamides
Explanation: **Explanation:** The correct answer is **B. Cephalosporins**. **Mechanism of Action:** Cephalosporins are **Beta-lactam antibiotics** that act by inhibiting bacterial cell wall synthesis. They bind to and inhibit **Penicillin-Binding Proteins (PBPs)**, which are enzymes (transpeptidases) responsible for cross-linking peptidoglycan chains. This disruption leads to a weakened cell wall, resulting in osmotic lysis and bacterial death (bactericidal action). **Analysis of Incorrect Options:** * **A. Erythromycin:** This is a Macrolide that inhibits **protein synthesis** by binding to the **50S ribosomal subunit**. * **C. Chloramphenicol:** This drug also inhibits **protein synthesis** by binding to the **50S ribosomal subunit** and preventing peptide bond formation. * **D. Sulfonamides:** These are antimetabolites that inhibit **folic acid synthesis** by competitively inhibiting the enzyme dihydropteroate synthase. **High-Yield Clinical Pearls for NEET-PG:** * **Cell Wall Inhibitors:** Remember the mnemonic **"V-P-C-B"** (Vancomycin, Penicillins, Cephalosporins, Bacitracin/Cycloserine). * **Bactericidal vs. Bacteriostatic:** Most cell wall inhibitors (like Cephalosporins) are **bactericidal**, whereas most protein synthesis inhibitors (except Aminoglycosides) are **bacteriostatic**. * **Cross-Reactivity:** Patients with a history of severe immediate hypersensitivity (anaphylaxis) to Penicillins should avoid Cephalosporins due to a 5-10% risk of cross-reactivity. * **Resistance:** The most common mechanism of resistance against Cephalosporins is the production of **Beta-lactamases**.
Question 279: What is the mechanism of action of Oseltamivir and Zanamivir?
- A. DNA polymerase inhibition
- B. Inhibition of viral mRNA
- C. Blocking viral uncoating
- D. Neuraminidase inhibition (Correct Answer)
Explanation: **Mechanism of Action: Neuraminidase Inhibitors** **Correct Answer: D. Neuraminidase inhibition** Oseltamivir and Zanamivir are structural analogs of sialic acid. Their primary mechanism involves the competitive inhibition of **Neuraminidase (NA)**, an enzyme found on the surface of Influenza A and B viruses. * **The Concept:** During the viral life cycle, new virions bud from the host cell membrane but remain attached via hemagglutinin to sialic acid receptors. Neuraminidase cleaves these receptors, allowing the release of progeny virions. By inhibiting this enzyme, Oseltamivir and Zanamivir cause the newly formed viruses to clump together and remain stuck to the host cell, thereby preventing the infection of new cells. **Why other options are incorrect:** * **A & B (DNA polymerase/mRNA inhibition):** These are mechanisms typical of anti-herpetic drugs (e.g., Acyclovir) or certain RNA polymerase inhibitors (e.g., Ribavirin). Influenza is an RNA virus, and these drugs do not target its genetic replication directly. * **C (Blocking viral uncoating):** This is the mechanism of **Amantadine and Rimantadine**, which inhibit the **M2 ion channel** [3]. These drugs are now largely obsolete due to widespread resistance. **High-Yield Clinical Pearls for NEET-PG:** * **Timing:** These drugs are most effective when started within **48 hours** of symptom onset [1], [2]. * **Routes:** Oseltamivir is **oral** (prodrug) [2], while Zanamivir is **inhaled** (contraindicated in asthma/COPD due to risk of bronchospasm). * **Peramivir:** An intravenous neuraminidase inhibitor used for acute uncomplicated influenza. * **Baloxavir Marboxil:** A newer agent that inhibits **cap-dependent endonuclease**, blocking viral mRNA synthesis (a frequent "next-step" question).
Question 280: Which of the following antimicrobial agents inhibits protein synthesis by blocking translocation?
- A. Aminoglycosides
- B. Tetracyclines
- C. Macrolides (Correct Answer)
- D. Chloramphenicol
Explanation: **Explanation:** Protein synthesis inhibitors are a high-yield topic in NEET-PG. To understand the mechanism, one must identify the specific step of translation being targeted. **1. Why Macrolides are correct:** Macrolides (e.g., Erythromycin, Azithromycin) bind to the **50S ribosomal subunit**. Their primary mechanism is inhibiting the **translocation** step. During translocation, the peptidyl-tRNA moves from the A-site (Aminoacyl) to the P-site (Peptidyl) on the ribosome. Macrolides block this movement, effectively "freezing" the protein chain elongation. **2. Analysis of Incorrect Options:** * **Aminoglycosides (A):** These bind to the **30S subunit**. Their primary action is causing **mRNA misreading** and inhibiting the initiation complex formation, rather than blocking translocation. * **Tetracyclines (B):** These bind to the **30S subunit** and block the **attachment of aminoacyl-tRNA to the A-site**. They prevent the "entry" of new amino acids. * **Chloramphenicol (D):** This binds to the **50S subunit** but specifically inhibits **peptidyl transferase**, the enzyme responsible for forming peptide bonds between amino acids. **3. Clinical Pearls for NEET-PG:** * **Mnemonic for 50S inhibitors:** "**C**ell **C**an't **M**ake **L**ong **P**eptides" (**C**hloramphenicol, **C**lindamycin, **M**acrolides, **L**inezolid, **P**leuromutilins). * **Resistance Mechanism:** The most common resistance to Macrolides is via **methylation of the 23S rRNA** (target site modification by *erm* genes). * **Prokinetic effect:** Erythromycin acts as a motilin receptor agonist, used clinically in gastroparesis.
Practice by Chapter
Beta-Lactam Antibiotics
Practice Questions
Aminoglycosides
Practice Questions
Macrolides and Ketolides
Practice Questions
Tetracyclines
Practice Questions
Quinolones
Practice Questions
Sulfonamides and Trimethoprim
Practice Questions
Antimycobacterial Drugs
Practice Questions
Antifungal Agents
Practice Questions
Antiviral Drugs
Practice Questions
Antiparasitic Agents
Practice Questions
Principles of Antimicrobial Selection
Practice Questions
Antimicrobial Resistance
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free